These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. Substitution of the carboxyl-terminal domain of apo AI with apo AII sequences restores the potential of HDL to reduce the progression of atherosclerosis in apo E knockout mice. Holvoet P; Danloy S; Deridder E; Lox M; Bernar H; Dhoest A; Collen D J Clin Invest; 1998 Jul; 102(2):379-85. PubMed ID: 9664079 [TBL] [Abstract][Full Text] [Related]
49. Murine amyloid protein AA in casein-induced experimental amyloidosis. Skinner M; Shirahama T; Benson MD; Cohen AS Lab Invest; 1977 Apr; 36(4):420-7. PubMed ID: 403374 [TBL] [Abstract][Full Text] [Related]
50. Polymorphism of tissue and serum amyloid A (AA and SAA) proteins in the mouse. Gorevic PD; Levo Y; Frangione B; Franklin EC J Immunol; 1978 Jul; 121(1):138-40. PubMed ID: 670697 [TBL] [Abstract][Full Text] [Related]
51. Rat apolipoprotein A-IV contains 13 tandem repetitions of a 22-amino acid segment with amphipathic helical potential. Boguski MS; Elshourbagy N; Taylor JM; Gordon JI Proc Natl Acad Sci U S A; 1984 Aug; 81(16):5021-5. PubMed ID: 6591177 [TBL] [Abstract][Full Text] [Related]
52. Apolipoprotein(a): structure-function relationship at the lysine-binding site and plasminogen activator cleavage site. Anglés-Cano E; Rojas G Biol Chem; 2002 Jan; 383(1):93-9. PubMed ID: 11928826 [TBL] [Abstract][Full Text] [Related]
53. Structural relationship of human apolipoprotein B48 to apolipoprotein B100. Innerarity TL; Young SG; Poksay KS; Mahley RW; Smith RS; Milne RW; Marcel YL; Weisgraber KH J Clin Invest; 1987 Dec; 80(6):1794-8. PubMed ID: 3680528 [TBL] [Abstract][Full Text] [Related]
54. Rabbit apolipoprotein A-I mRNA and gene. Evidence that rabbit apolipoprotein A-I is synthesized in the intestine but not in the liver. Pan TC; Hao QL; Yamin TT; Dai PH; Chen BS; Chen SL; Kroon PA; Chao YS Eur J Biochem; 1987 Dec; 170(1-2):99-104. PubMed ID: 3121329 [TBL] [Abstract][Full Text] [Related]
55. Amyloid fibrils formed by selective N- and C-terminal sequences of mouse apolipoprotein A-II. Sawashita J; Kametani F; Hasegawa K; Mori M; Naiki H; Higuchi K Amyloid; 2011 Jun; 18 Suppl 1():19-21. PubMed ID: 21838418 [No Abstract] [Full Text] [Related]
56. Characterization of human high-density lipoprotein subclasses LP A-I and LP A-I/A-II and binding to HepG2 cells. Kilsdonk EP; Van Gent T; Van Tol A Biochim Biophys Acta; 1990 Aug; 1045(3):205-12. PubMed ID: 2167131 [TBL] [Abstract][Full Text] [Related]
57. Amyloid fibril protein related to immunoglobulin lambda-chains. Skinner M; Benson MD; Cohen AS J Immunol; 1975 Apr; 114(4):1433-5. PubMed ID: 804011 [TBL] [Abstract][Full Text] [Related]
58. Prediction of the tertiary structure of apolipoprotein A-II by computer modeling. De Coen JL; Delcroix C; Lontie JF; Malmendier CL Adv Exp Med Biol; 1988; 243():133-7. PubMed ID: 3146909 [No Abstract] [Full Text] [Related]
59. Role of Conserved Proline Residues in Human Apolipoprotein A-IV Structure and Function. Deng X; Walker RG; Morris J; Davidson WS; Thompson TB J Biol Chem; 2015 Apr; 290(17):10689-702. PubMed ID: 25733664 [TBL] [Abstract][Full Text] [Related]
60. C-terminal sequence of amyloid-resistant type F apolipoprotein A-II inhibits amyloid fibril formation of apolipoprotein A-II in mice. Sawashita J; Zhang B; Hasegawa K; Mori M; Naiki H; Kametani F; Higuchi K Proc Natl Acad Sci U S A; 2015 Feb; 112(8):E836-45. PubMed ID: 25675489 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]